Ligand Pharm (LGND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Sales | 24,516 | 13,308 | 16,112 | 5,545 | 1,526 |
| Cost of Goods | 0 | 0 | 24,301 | 14,220 | 6,228 |
| Gross Profit | 24,516 | 13,308 | -8,189 | -8,675 | -4,702 |
| Operating Expenses | 49,817 | 34,161 | 6,493 | 4,365 | 1,796 |
| Operating Income | -25,301 | -20,853 | -14,381 | -12,819 | -6,270 |
| Interest Expense | 5,410 | 679 | 354 | 325 | 216 |
| Other Income | -33,461 | -5,548 | -4,723 | -863 | 211 |
| Pre-tax Income | -64,172 | -27,080 | -19,458 | -14,007 | -6,274 |
| Net Income Continuous | -51,607 | -27,079 | -19,458 | -14,007 | -6,274 |
| Net Income | $-64,172 | $-27,080 | $-19,458 | $-14,007 | $-6,274 |
| EPS Basic Total Ops | -16.20 | -9.42 | -7.10 | -5.43 | -17.12 |
| EPS Basic Continuous Ops | -13.01 | -9.42 | -6.91 | -5.13 | -17.12 |
| EPS Diluted Total Ops | -16.20 | -9.42 | -7.14 | -5.13 | -17.12 |
| EPS Diluted Continuous Ops | -13.01 | -9.42 | -6.91 | -5.13 | -17.12 |
| EBITDA(a) | $-22,614 | $-19,317 | $-13,112 | $-11,968 | $-5,495 |